Greg Mayes is the founder of Antios Therapeutics. Antios Therapeutics has raised $171M in total funding. Latest round: Series B. Based in Doylestown, PA.
Greg Mayes is the former President and CEO of Antios Therapeutics, a clinical-stage biopharmaceutical company. He led a $100+ million Series B financing in 2021 and advanced the company's lead hepatitis B drug ATI-2173 through Phase 2b development. Mayes currently serves as President and CEO of Reunion Neuroscience Inc.
Full founder directory · Investor directory · Company funding database · Fundraising library